Hermetica Superfood Encyclopedia
Euterpe oleracea (açaí) contains anthocyanins and phenolic compounds that enhance antioxidant enzyme activity and reduce cellular oxidative stress. Studies show it increases HDL cholesterol and boosts glutathione levels through upregulation of antioxidant defense pathways.


Euterpe oleracea, commonly known as açaí, is a palm tree native to the Amazon rainforest, particularly abundant in Brazil, where its fruits, seeds, leaves, and oil are harvested. The fruit and seeds are processed using methods including hydroalcoholic extraction or preparation of juices and standardized extracts rich in phenolic compounds.
Clinical evidence remains limited with no large-scale RCTs or meta-analyses identified; most data derive from small pilot studies and integrative reviews. An integrative review of trials up to 2021 found suggestions of antioxidant and metabolic benefits from juice consumption, while a 60-day trial in overweight, dyslipidemic individuals showed reduced oxidative stress when açaí was added to a hypoenergetic diet. A systematic review by Natural Standard graded evidence as low due to study quality limitations.

Human clinical trials have primarily used juice or pulp forms with limited standardization details. One pilot study used a polyphenol-standardized açaí beverage for metabolic syndrome (exact dosage unspecified). Preclinical studies used hydroalcoholic seed extract at 10-100 mg/kg orally, with 100 mg/kg showing effectiveness. No maximum safe doses have been established for human use. Consult a healthcare provider before starting any new supplement.
Per 100 g of freeze-dried açaí (Euterpe oleracea) pulp/skin powder: Energy ~534 kcal; Total fat ~32–40 g (predominantly oleic acid ~56% of fatty acids, palmitic acid ~24%, linoleic acid ~12%); Protein ~8–13 g; Total carbohydrates ~36–52 g (of which dietary fiber ~25–34 g, predominantly insoluble); Sugars ~1–2 g (very low glycemic profile). KEY BIOACTIVE COMPOUNDS: Anthocyanins 319–1,040 mg/100 g dry weight, primarily cyanidin-3-glucoside (~124–296 mg/100 g) and cyanidin-3-rutinoside (~126–350 mg/100 g); Total polyphenols (Folin-Ciocalteu) ~3,000–4,500 mg GAE/100 g dry weight; Proanthocyanidins (condensed tannins) ~1,289–2,100 mg/100 g; Orientin, homoorientin, vitexin, isovitexin, and other C-glycosyl flavones present at ~10–50 mg/100 g each; Ellagic acid and derivatives detected at lower concentrations (~1–5 mg/100 g). MINERALS: Calcium ~260–330 mg; Potassium ~900–1,100 mg; Magnesium ~174–260 mg; Iron ~4–26 mg (variability due to soil and processing); Manganese ~12–22 mg; Zinc ~3–7 mg; Phosphorus ~120–170 mg; Copper ~1.5–2.5 mg; Sodium ~30–56 mg. VITAMINS: Vitamin E (predominantly α-tocopherol ~45 mg/100 g, plus δ-tocopherol ~8 mg/100 g and γ-tocopherol ~3 mg/100 g); Vitamin C ~0–10 mg (largely degraded during processing); B-vitamins (B1 ~0.4 mg, B2 ~0.02 mg, B3 ~0.4 mg — relatively modest). Phytosterols: β-sitosterol ~78–89 mg/100 g, campesterol, and stigmasterol present. ORAC antioxidant capacity reported at ~102,700 µmol TE/100 g (freeze-dried powder), among the highest recorded for fruits. BIOAVAILABILITY NOTES: Anthocyanin bioavailability is generally low (~1–5% absorption), but the acylated and rutinoside forms in açaí may show slightly improved colonic stability and microbial metabolite generation (hippuric acid, protocatechuic acid detected as plasma metabolites); co-consumption with the fruit's native lipid fraction (~33% fat) may enhance absorption of fat-soluble antioxidants (tocopherols, phytosterols); high fiber content may slow gastric transit and modulate polyphenol release in the colon; iron bioavailability may be reduced by high tannin/proanthocyanidin content (chelation effect); freeze-drying preserves polyphenol content significantly better than spray-drying or thermal pasteurization (up to 50% anthocyanin loss with heat processing).
Açaí's anthocyanins and phenolic acids activate the Nrf2 pathway, upregulating antioxidant enzymes including glutathione (GSH) and catalase (CAT). These compounds neutralize reactive oxygen species and reduce lipid peroxidation markers like malondialdehyde (MDA). The phenolic profile also modulates lipid metabolism pathways, contributing to improved HDL cholesterol synthesis.
Small pilot studies have demonstrated açaí's ability to reduce oxidative stress markers, with one study showing decreased MDA levels and increased GSH and CAT activity. An integrative review of clinical trials suggests positive effects on HDL cholesterol and antioxidant enzyme activities. However, most studies involve small sample sizes and short-term interventions. The evidence base remains limited and requires larger, longer-duration randomized controlled trials for definitive therapeutic claims.
Açaí is generally well-tolerated as a food supplement with minimal reported adverse effects. Potential allergic reactions may occur in individuals sensitive to palm family plants. No significant drug interactions have been documented, though theoretical interactions with anticoagulant medications may exist due to phenolic compounds. Pregnancy and lactation safety data are limited, requiring caution in these populations.